Read news on positive phase with our app.
Read more in the app
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211
